The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

G Conway, D Dewailly… - European journal of …, 2014 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

The diagnosis of polycystic ovary syndrome during adolescence

SF Witchel, S Oberfield, RL Rosenfield… - Hormone research in …, 2015 - karger.com
Abstract Background/Aims: The diagnostic criteria for polycystic ovary syndrome (PCOS) in
adolescence are controversial, primarily because the diagnostic pathological features used …

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

RS Legro, SA Arslanian, DA Ehrmann… - The Journal of …, 2013 - academic.oup.com
Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS

M Irani, H Minkoff, DB Seifer… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Elevation of serum proinflammatory advanced glycation end products (AGEs) is
involved in the pathogenesis of polycystic ovary syndrome (PCOS). The soluble receptor for …

Labor and delivery outcomes among young adolescents

AJ Torvie, LS Callegari, MA Schiff, KE Debiec - American journal of …, 2015 - Elsevier
Objective We sought to determine whether young adolescents aged 11-14 years and teens
aged 15-17 and 18-19 years have an increased risk of cesarean or operative delivery, as …

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients

CL Chang, SY Huang, YC Hsu, TH Chin, YK Soong - Scientific reports, 2019 - nature.com
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, oligo-
or anovulation, and/or polycystic ovary. It frequently presents with dyslipidemia and insulin …

Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women

KA Kissell, MR Danaher, EF Schisterman… - Human …, 2014 - academic.oup.com
STUDY QUESTION Does serum anti-Müllerian hormone (AMH) vary significantly throughout
both ovulatory and sporadic anovulatory menstrual cycles in healthy premenopausal …

Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis

Y Tsukui, Y Kitahara, Y Hasegawa, M Kobayashi… - Endocrine …, 2022 - jstage.jst.go.jp
Polycystic ovary syndrome (PCOS) is an endocrine disorder that causes menstrual cycle
irregularities and infertility. PCOS is diagnosed based on hyperandrogenism, polycystic …

Anti‐müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development

M Lindhardt Johansen, CP Hagen… - International journal …, 2013 - Wiley Online Library
Using measurements of circulating anti‐Müllerian hormone (AMH) in diagnosing and
managing reproductive disorders in pediatric patients requires thorough knowledge on …

Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome

CL Chang, SY Huang, YK Soong… - The Journal of …, 2014 - academic.oup.com
Context: Polycystic ovary syndrome (PCOS) is characterized by oligo-or anovulation,
polycystic ovary, and/or hyperandrogenism. In addition, many PCOS patients present with …